{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:00:20Z","timestamp":1780916420226,"version":"3.54.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC 2015 IG 17464"],"award-info":[{"award-number":["AIRC 2015 IG 17464"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009701","name":"Fondazione Giovanni Goria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Reviews in Mutation Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mrrev.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T11:40:17Z","timestamp":1551872417000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Genetic predisposition for malignant mesothelioma: A concise review"],"prefix":"10.1016","volume":"781","author":[{"given":"Marta","family":"Betti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4944-0990","authenticated-orcid":false,"given":"Anna","family":"Aspesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Sculco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Matullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Dianzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrrev.2019.03.001_bib0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S1470-2045(13)70257-2","article-title":"Asbestos is not just asbestos: an unrecognised health hazard","volume":"14","author":"Baumann","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0010","volume":"vol. 111","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2017"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0015","unstructured":"C. Magnani, B. Fubini, D. Mirabelli, P.A. Bertazzi, C. Bianchi, E. Chellini, V. Gennaro, A. Marinaccio, M. Menegozzo, E. Merler, F. Merletti, M. Musti, E. Pira, A. Romanelli, B. Terracini, A. Zona, Pleural mesothelioma: epidemiological and public health issues. Report from the Second Italian Consensus Conference on Pleural Mesothelioma., Med. Lav. 104 (n.d.) 191\u2013202."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.critrevonc.2016.05.004","article-title":"The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: state of the art and recommendations","volume":"104","author":"Novello","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12995-016-0127-4","article-title":"Malignant mesothelioma incidence by nation-wide cancer registry: a population-based study","volume":"11","author":"Tomasson","year":"2016","journal-title":"J. Occup. Med. Toxicol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0030","volume":"vol. XI","author":"Bray","year":"2017"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/1403494815596500","article-title":"Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden","volume":"43","author":"J\u00e4rvholm","year":"2015","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/oemed-2015-102803","article-title":"Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment","volume":"73","author":"Ferrante","year":"2016","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0003-4878(00)00045-4","article-title":"The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure","volume":"44","author":"Hodgson","year":"2000","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mrrev.2007.08.001","article-title":"Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor","volume":"658","author":"Ugolini","year":"2008","journal-title":"Mutat. Res. Mutat. Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2068","article-title":"A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes","volume":"7","author":"Carbone","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.21037\/atm.2017.04.06","article-title":"The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad","volume":"5","author":"Emri","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1023032214444","article-title":"A one-generation cluster of malignant mesothelioma within a family reveals exposure to asbestos-contaminated jute bags in Naples, Italy","volume":"18","author":"Ascoli","year":"2003","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ajim.20451","article-title":"Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature","volume":"50","author":"Ascoli","year":"2007","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.canep.2014.02.014","article-title":"Familial malignant mesothelioma: a population-based study in central Italy (1980-2012)","volume":"38","author":"Ascoli","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0080","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1289\/ehp.10195","article-title":"Cancer mortality and incidence of mesothelioma in a cohort of wives of asbestos workers in Casale Monferrato, Italy","volume":"115","author":"Ferrante","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0085","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrc.2017.82","article-title":"Genome-wide association studies of cancer: current insights and future perspectives","volume":"17","author":"Sud","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0090","article-title":"Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study","volume":"599","author":"Dianzani","year":"2006","journal-title":"Mutat. Res. - Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mrrev.2008.02.002","article-title":"Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases","volume":"659","author":"Neri","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0100","first-page":"11","article-title":"XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study","volume":"708","author":"Betti","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0105","first-page":"5418","article-title":"High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma","volume":"62","author":"Bolognesi","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0110","series-title":"Biomarkers of Enviromentally Associated Disease","first-page":"pp. 84","article-title":"Studies of DNA repair and human cancer: an update","author":"Berwick","year":"2002"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061253","article-title":"Genetic Variants Associated with Increased Risk of Malignant Pleural Mesothelioma: A Genome-Wide Association Study","volume":"8","author":"Matullo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2013.04.018","article-title":"A genome-wide association study for malignant mesothelioma risk","volume":"82","author":"Cadby","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgv097","article-title":"Gene-asbestos interaction in malignant pleural mesothelioma susceptibility","volume":"36","author":"Tunesi","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0130","series-title":"Modern Epidemiology","author":"Rothman","year":"2008"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JTO.0b013e3181951ce8","article-title":"In arrayed ranks: array technology in the study of mesothelioma","volume":"4","author":"Gray","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0140","article-title":"Peripheral blood DNA methylation as potential biomarker of Malignant Pleural Mesothelioma in asbestos-exposed subjects","author":"Guarrera","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0145","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0150","series-title":"BAP1 Tumor Predisposition Syndrome, GeneReviews","author":"Pilarski","year":"2016"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/gcc.22218","article-title":"Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area","volume":"54","author":"Betti","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-15-0295","article-title":"Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of Cancer","volume":"76","author":"Ohar","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0180","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2018.79.0352","article-title":"A subset of mesotheliomas with improved survival occurring in carriers of BAP1 and other germline mutations","volume":"36","author":"Pastorino","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0185","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat. Genet."},{"issue":"194","key":"10.1016\/j.mrrev.2019.03.001_bib0190","article-title":"Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members","volume":"16","author":"Kittaneh","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0195","first-page":"573","article-title":"Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes, Genes","volume":"57","author":"Betti","year":"2018","journal-title":"Chromosom. Cancer."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","volume":"89","author":"Rai","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0205","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases","volume":"53","author":"Pilarski","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cge.12501","article-title":"A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma","volume":"88","author":"Wadt","year":"2015","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0220","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.canlet.2015.09.011","article-title":"Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction","volume":"369","author":"Cheung","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cge.12472","article-title":"Germline BAP1 mutations predispose also to multiple basal cell carcinomas","volume":"88","author":"de la Fouchardi\u00e8re","year":"2015","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0235","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"Wadt","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072144","article-title":"A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers","volume":"8","author":"Aoude","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cancergen.2015.12.007","article-title":"A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer","volume":"209","author":"McDonnell","year":"2016","journal-title":"Cancer Genet."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0250","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide","author":"Walpole","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2014.10.017","article-title":"Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases","volume":"87","author":"Rusch","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gene.2015.03.031","article-title":"Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma","volume":"563","author":"Sneddon","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0265","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0270","doi-asserted-by":"crossref","first-page":"28643","DOI":"10.1074\/jbc.M115.661553","article-title":"The BAP1\/ASXL2 histone H2A deubiquitinase complex regulates cell proliferation and is disrupted in Cancer","volume":"290","author":"Daou","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0275","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.1309085110","article-title":"Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair","volume":"111","author":"Yu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0280","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1093\/nar\/gku274","article-title":"The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex","volume":"42","author":"Ji","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0285","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/cdd.2017.95","article-title":"Germline BAP1 mutations induce a Warburg effect","volume":"24","author":"Bononi","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0290","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","article-title":"Germline mutations in BAP1 impair its function in DNA double-strand break repair","volume":"74","author":"Ismail","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0295","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.1228463","article-title":"Cancer. Emerging anatomy of the BAP1 tumor suppressor system","volume":"337","author":"White","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0300","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/onc.2015.243","article-title":"Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","volume":"35","author":"Napolitano","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0305","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0310","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0315","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10937404.2016.1195322","article-title":"Environmental risk of mesothelioma in the United States: an emerging concern\u2014epidemiological issues","volume":"19","author":"Baumann","year":"2016","journal-title":"J. Toxicol. Environ. Heal. B"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005633","article-title":"Combined genetic and genealogic studies uncover a large BAP1 Cancer syndrome kindred tracing back nine generations to a common ancestor from the 1700s","volume":"11","author":"Carbone","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0325","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.jtho.2016.06.020","article-title":"BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study","volume":"11","author":"Righi","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0330","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study","volume":"10","author":"Lo Iacono","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0335","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2016.05.011","article-title":"CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma","volume":"378","author":"Betti","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0345","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2017.06.028","article-title":"Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma","volume":"405","author":"Betti","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0350","series-title":"BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer, GeneReviews","author":"Petrucelli","year":"2016"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0355","series-title":"Fanconi Anemia, GeneReviews","author":"Mehta","year":"2018"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0360","series-title":"Xeroderma Pigmentosum, GeneReviews","author":"Kraemer","year":"2016"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0365","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10689-004-7993-0","article-title":"Lynch syndrome genes","volume":"4","author":"Peltom\u00e4ki","year":"2005","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0370","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2013.04.030","article-title":"The mismatch repair gene hPMS1 (human postmeiotic segregation1) is down regulated in oral squamous cell carcinoma","volume":"524","author":"Wang","year":"2013","journal-title":"Gene."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0375","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/pcmr.12333","article-title":"Genetics of familial melanoma: 20 years after CDKN2A","volume":"28","author":"Aoude","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0380","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2010.34.1933","article-title":"Malignant peritoneal mesothelioma in a patient with Li-Fraumeni syndrome","volume":"29","author":"Ceelen","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0385","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10689-005-0659-8","article-title":"Neurofibromatosis 2 (NF2) and malignant mesothelioma in a man with a constitutional NF2 missense mutation","volume":"4","author":"Baser","year":"2005","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0390","doi-asserted-by":"crossref","first-page":"113673","DOI":"10.18632\/oncotarget.22817","article-title":"Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma","volume":"8","author":"Hylebos","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0395","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nature23306","article-title":"Integrative clinical genomics of metastatic cancer","volume":"548","author":"Robinson","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0400","first-page":"123","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers., N. Engl","volume":"361","author":"Fong","year":"2009","journal-title":"J. Med."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0405","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1470-2045(16)30559-9","article-title":"Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial","volume":"18","author":"Swisher","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0410","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science (80-.)"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0415","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/2159-8290.CD-16-0860","article-title":"Targeting DNA repair in Cancer: beyond PARP inhibitors","volume":"7","author":"Brown","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0420","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.2147\/OTT.S139336","article-title":"Current status of poly(ADP-ribose) polymerase inhibitors and future directions","volume":"10","author":"Ohmoto","year":"2017","journal-title":"Onco. Ther."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0425","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrrev.2019.03.001_bib0430","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.3947","article-title":"Loss of BAP1 function leads to EZH2-dependent transformation","volume":"21","author":"LaFave","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.mrrev.2019.03.001_bib0435","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1586\/17476348.2015.1081066","article-title":"Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies","volume":"9","author":"Bononi","year":"2015","journal-title":"Expert Rev. Respir. Med."}],"container-title":["Mutation Research\/Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574218300656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574218300656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:29:03Z","timestamp":1778606943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574218300656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":87,"alternative-id":["S1383574218300656"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2019.03.001","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic predisposition for malignant mesothelioma: A concise review","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}